Company Filing History:
Years Active: 2002-2003
Title: The Innovations of Régis Steinberg
Introduction
Régis Steinberg is a notable inventor based in Prades le Lez, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mood disorders. With a total of two patents to his name, Steinberg's work has the potential to impact many lives.
Latest Patents
Steinberg's latest patents include the use of saredutant for the treatment of adaptation, bipolar, and dysthymic disorders. This invention relates to the use of saredutant and its pharmaceutically acceptable salts for the treatment or prevention of these disorders. Another significant patent involves osanetant in the treatment of depression and depressive disorders. This invention outlines a method for treating mood disorders utilizing osanetant or a pharmaceutically acceptable salt thereof.
Career Highlights
Régis Steinberg is associated with Sanofi-Synthelabo, a leading pharmaceutical company. His work there has allowed him to focus on innovative treatments that address critical mental health issues. His contributions are recognized within the industry for their potential to improve patient outcomes.
Collaborations
Steinberg has collaborated with notable colleagues such as Xavier Emonds-Alt and Philippe Soubrie. These partnerships have fostered an environment of innovation and shared expertise, enhancing the development of new therapeutic solutions.
Conclusion
Régis Steinberg's work exemplifies the impact of innovation in the pharmaceutical industry. His patents reflect a commitment to addressing significant mental health challenges through scientific advancement.